» Articles » PMID: 34122013

Role of P2X7 Receptors in Immune Responses During Neurodegeneration

Overview
Specialty Cell Biology
Date 2021 Jun 14
PMID 34122013
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

P2X7 receptors are ion-gated channels activated by ATP. Under pathological conditions, the extensive release of ATP induces sustained P2X7 receptor activation, culminating in induction of proinflammatory pathways with inflammasome assembly and cytokine release. These inflammatory conditions, whether occurring peripherally or in the central nervous system (CNS), increase blood-brain-barrier (BBB) permeability. Besides its well-known involvement in neurodegeneration and neuroinflammation, the P2X7 receptor may induce BBB disruption and chemotaxis of peripheral immune cells to the CNS, resulting in brain parenchyma infiltration. For instance, despite common effects on cytokine release, P2X7 receptor signaling is also associated with metalloproteinase secretion and activation, as well as migration and differentiation of T lymphocytes, monocytes and dendritic cells. Here we highlight that peripheral immune cells mediate the pathogenesis of Multiple Sclerosis and Parkinson's and Alzheimer's disease, mainly through T lymphocyte, neutrophil and monocyte infiltration. We propose that P2X7 receptor activation contributes to neurodegenerative disease progression beyond its known effects on the CNS. This review discusses how P2X7 receptor activation mediates responses of peripheral immune cells within the inflamed CNS, as occurring in the aforementioned diseases.

Citing Articles

Regulation of BzATP-Induced Blood-Brain Barrier Endothelial Cell Hyperpermeability by NLRP3 Inflammasome Inhibition.

Anderson A, Waithe O, Seplovich G, Olagunju O, Greene C, Singh A Microcirculation. 2025; 32(3):e70006.

PMID: 40052959 PMC: 11905927. DOI: 10.1111/micc.70006.


Bioinformatics insights into mitochondrial and immune gene regulation in Alzheimer's disease.

Meng T, Zhang Y, Ye Y, Li H, He Y Eur J Med Res. 2025; 30(1):89.

PMID: 39920860 PMC: 11806906. DOI: 10.1186/s40001-025-02297-w.


Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis.

Kocot J, Kosa P, Ashida S, Pirjanian N, Goldbach-Mansky R, Peterson K medRxiv. 2025; .

PMID: 39802756 PMC: 11722480. DOI: 10.1101/2024.04.09.24305506.


Neuroinflammatory responses and blood-brain barrier injury in chronic alcohol exposure: role of purinergic P2 × 7 Receptor signaling.

Togre N, Mekala N, Bhoj P, Mogadala N, Winfield M, Trivedi J J Neuroinflammation. 2024; 21(1):244.

PMID: 39342243 PMC: 11439317. DOI: 10.1186/s12974-024-03230-4.


Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease.

Juvenal G, Higa G, Bonfim Marques L, Tessari Zampieri T, Viana F, Britto L Purinergic Signal. 2024; .

PMID: 39046648 DOI: 10.1007/s11302-024-10034-x.


References
1.
Hardy J, Higgins G . Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992; 256(5054):184-5. DOI: 10.1126/science.1566067. View

2.
Yang F, Zhao K, Zhang X, Zhang J, Xu B . ATP Induces Disruption of Tight Junction Proteins via IL-1 Beta-Dependent MMP-9 Activation of Human Blood-Brain Barrier . Neural Plast. 2016; 2016:8928530. PMC: 5067334. DOI: 10.1155/2016/8928530. View

3.
Eyo U, Peng J, Swiatkowski P, Mukherjee A, Bispo A, Wu L . Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus. J Neurosci. 2014; 34(32):10528-40. PMC: 4200107. DOI: 10.1523/JNEUROSCI.0416-14.2014. View

4.
Di Virgilio F . Purinergic signalling in the immune system. A brief update. Purinergic Signal. 2008; 3(1-2):1-3. PMC: 2096765. DOI: 10.1007/s11302-006-9048-5. View

5.
Ribeiro D, Oliveira-Giacomelli A, Glaser T, Arnaud-Sampaio V, Andrejew R, Dieckmann L . Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry. 2020; 26(4):1044-1059. PMC: 7738776. DOI: 10.1038/s41380-020-00965-3. View